Toxic Adenoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}} ; {{AE}} {{ADG}} | {{CMG}} ; {{AE}} {{ADG}} | ||
==Overveiw== | ==Overveiw== | ||
Toxic adenoma prevalence is inversely related to a population’s dietary iodine sufficiency. | |||
==Epidemiology== | ==Epidemiology== | ||
===Prevalance=== | ===Prevalance=== | ||
Revision as of 17:55, 11 September 2017
|
Toxic Adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Template:T On the Web |
|
American Roentgen Ray Society Images of Toxic Adenoma epidemiology and demographics |
|
Risk calculators and risk factors for Toxic Adenoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overveiw
Toxic adenoma prevalence is inversely related to a population’s dietary iodine sufficiency.
Epidemiology
Prevalance
- Toxic adenoma prevalence is inversely related to a population’s dietary iodine sufficiency.
- In women and men, the prevalence rate of palpable nodules is 5-7% and 1-2%, respectively.
Demographics
Age
- The incidence of toxic adenoma increases with age; the median age at diagnosis is 50 years.[1]
- Toxic adenoma is more commonly seen in 56.5% of patients over 60 years but in only 12.5% of the younger patients.
Race
There is no racial predilection to toxic adenoma.
Gender
- Similar to any thyroid disease females are more commonly affected by toxic adenoma than males.
- In women and men, the prevalence rate of palpable nodules is 5-7% and 1-2%, respectively.
- The female-to-male ratio was 14.9:1 for nontoxic AFTNs and 5.9:1 for toxic AFTN patients
References
- ↑ Hamburger JI (1980). "Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules". J. Clin. Endocrinol. Metab. 50 (6): 1089–93. doi:10.1210/jcem-50-6-1089. PMID 7372787.